Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lasons India is an India-based manufacturer of pharmaceutical bulk drugs, vitamin ingredients, and specialty chemicals, with a core focus on Vitamin B3 products including niacin and niacinamide. Founded in 1979, the company began pharmaceutical bulk drug manufacturing in 1984 and serves pharmaceutical, food, feed, nutraceutical, cosmetic, and electroplating markets globally. Its business appears to be centered on commercial-scale production and export rather than a clinical development pipeline typical of biotech drug developers. Lasons also operates within a broader group structure that includes related businesses in vitamins and specialty chemicals, and has been associated with a consumer wellness division branded OneLife. Overall, it is best characterized as a commercial pharma ingredient and specialty chemical company rather than an R&D-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lasons India.